Skip to main content

Senate bill · S. 3014 (119th Congress)

Ensuring Timely Access to Generics Act of 2025

U.S. Senate

Latest action Oct 16, 2025

Sponsor: Jeanne Shaheen (U.S. Senator for New Hampshire, Democratic)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Amends section 505(q) of the Federal Food, Drug, and Cosmetic Act to modify how the Secretary determines whether a citizen petition was submitted with the primary purpose of delaying approval of a drug application.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

2

Cosponsors listed on Congress.gov, shown A to Z.

  • Democratic1
  • Republican1

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

As identified by Congress.gov.

Full history

  1. Oct 16, 2025

    Introduced

    Introduced in U.S. Senate

    U.S. Senate

  2. Oct 16, 2025

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  3. Oct 16, 2025

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  4. Oct 16, 2025

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Read the record